Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Essentia Biosystems closes $13mm Series B round

Executive Summary

Essentia Biosystems (develops aesthetic and therapeutic dermatology products) raised $13mm through a Series B financing led by Essex Woodlands Healthcare Ventures. Also participating in the round were Biotechnology Development Fund IV (managed by BioAsia Investments) and Technology Partners, along with existing investors and Essentia management.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies